Anna Greka

And so there's, you know, ASO, siRNA technologies, and then also actual gene editing technologies that we are investigating.

But I would say that, you know, some of them are closer than others.

And again, to your question about patients, I tell them, honestly, when a project looks to be more promising.

And I also tell them when a project looks to have hurdles and that it will take long and that sometimes I just don't know how long it will take before we can get there.

So the only thing that I can promise patients,

In any of our projects, whether it's Alzheimer's, blindness, kidney disease, all I can promise is that we're working the hardest we possibly can on the problem.

And I think that is often reassuring, I have found, to patients.

And it's best to be honest about the fact that these things take a long time.

But I do think that they find it reassuring that someone is on it.

essentially, and that there will be some progress as we move forward.

And we've made progress.

In the very first discovery that came out of my lab, as I mentioned to you, we've made it all the way to phase two trials.

So I have seen the trajectory be realized, and I'm eager to make it happen again and again as many times as I can within my career to help as many people as possible.

I think you're absolutely right.

And this is, again, something that in my leadership of the ACI, I have made sort of a cornerstone of our efforts.

I think that it has been well documented as a problem.

I think that the pressures of modern clinical care are really antithetical to the needs of research.

you know, protected time to really be able to think and be creative and, you know, even have the funding available to be able to, you know, pursue one's program.

I think those pressures are becoming so heavy for investigators that many of them, you know, kind of choose one or the other route, most often the clinical route, because, you know, that tends to be, of course, where they can support their families better.

And so this has been...